RPRX
Royalty Pharma PLC
$59.23
0.14 (0.24%) Today
0.87 (1.49%) After-hours
— up— down
Market Cap
$33.48B+65.4%
Revenue (TTM)
$2.62B+10.0%
Net Income (TTM)
$841.00M-15.9%
EPS (TTM)
1.46-15.9%
Shares Out
575.83M
575.83MP/E Ratio
41.12
41.12Forward P/E
10.39
10.39Dividend
$0.65 (2.96%)
$0.65 (2.96%)Ex-Dividend Date
Aug 14, 2026
Aug 14, 2026Open
$58.21
$58.21Previous Close
$58.22
$58.22Day Range
$57.70 – $58.64
$57.70 – $58.6452-Week Range
$35.23 – $64.38
$35.23 – $64.38Beta
0.39
0.39Volume
3.65M
3.65MAvg Volume
3.32M
3.32MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout RPRX
Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.
Related
News
If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today
Benzinga · 1d ago
Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts
Yahoo · 5d ago
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
Yahoo · 5d ago
Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SeekingAlpha · 1w ago
Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run
Yahoo · 1w ago